Living Cell Technologies in trading halt pending Parkinson's trial result

ASX-listed Kiwi biotech firm Living Cell Technologies is in a trading halt until tomorrow when it expects to announce the results of a clinical trial testing its treatment for Parkinson’s disease. The Melbourne-based company’s Phase…